NCT00052000View on ClinicalTrials.gov

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2002

Conditions
Prostate Cancer
Interventions
DRUG

MLN2704 (DM1 conjugated monoclonal antibody MLN591)

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

21231

The Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins, Baltimore

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY